Skip to content

4Accepted Oct 2, 4:24 PM ET

Bristol Myers Squibb Co: director Derica W Rice received 620.994 shares

BMYBRISTOL MYERS SQUIBB CO

Accepted (ET)

4:24 PM

Oct 2, 2026

Filed

Oct 2, 2026

Documents

1

Size

5.8 KB

Summary

Bristol Myers Squibb Co: director Derica W Rice received 620.994 shares

Updated

What happened

  • Derica W Rice, a director, received 620.994 deferred share units (derivative award) on Sep 30, 2026, at $62.40 per share, with a reported value of $38,750. The transaction type is listed as A (award/grant or other acquisition).

Key details

  • Transaction date and price: Sep 30, 2026; 620.994 units at $62.40 each.
  • Amount acquired: 620.994 deferred share units; total reported value $38,750.
  • Shares owned after the transaction: not reported in this Form 4.
  • Relevant footnotes:
    • F1: Each deferred share unit will be converted into a share of common stock upon settlement. The units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
    • F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
  • Filing date: filed on Oct 02, 2026.

Why it may matter

  • This was a derivative award of deferred share units that will convert into common stock upon settlement as described in F1.
  • The award is part of deferred compensation and dividend reinvestment arrangements per F2.
  • A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing